case_images: PMC9618854_01
case_images: Changes in the electrocardiogram. (A) after admission; (B) on day twelve of admission.
case_images: fphar-13-900701-g001.jpg
case_images: PMC9618854_01_fphar-13-900701-g001.jpg
case_images: F1
case_images: Electrocardiogram (ECG) showed a low T-wave that was flat and inverted in leads II and III, and aVF (Figure 1). The ECG changes before and after the treatment are shown in Figure 1.
case_images: The red arrow represents the start of the use of glucocorticoids. The green arrow represents the levothyroxine administration. The numbered green arrows indicate the administered doses as follows: 1, 25 mg/d; 2, 50 mg/d; 3, 100 mg/d; 4, 125 mg/d. The following are also shown: (A) thyroid-stimulating hormone, free triiodothyronine, and, free thyroxine; (B) thyroid peroxidase antibody and thyroglobulin antibodies; (C) PO2, FiO2, and oxygenation index; (D) white blood cell count and NE%.
case_images: fphar-13-900701-g002.jpg
case_images: PMC9618854_01_fphar-13-900701-g002.jpg
case_images: F2
case_images: The fraction of inspired oxygen improvement, as well as white blood cell count throughout the therapy process are shown in Figure 2.
case_images: A comparison of pulmonary computed tomography (A) before glucocorticoids administration, (B) after weaning, and (C) before discharge.
case_images: fphar-13-900701-g003.jpg
case_images: PMC9618854_01_fphar-13-900701-g003.jpg
case_images: F3
case_images: The CT changes in the patient's lungs are shown in Figure 3.